Berlin - Delayed Quote • EUR Equillium Inc (0FY.BE) Follow Compare 0.6410 0.0000 (0.00%) At close: January 31 at 9:52:10 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0FY.BE 1D 5D -3.17% 1M -4.61% 3M -49.92% 6M -7.37% YTD -4.61% 1Y -16.75% 5Y -94.70% All -94.70% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 0FY.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations US Penny Stocks To Watch In January 2025 Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates Equillium to Present at the Stifel Healthcare Conference Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates Equillium Maintains Rights to Itolizumab Following Ono Partnership Alto Ingredients And 2 Other US Penny Stocks To Watch Closely Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer Equillium collaborates with Vivtex for oral formulation of autoimmune therapy Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit Related Tickers FYB.F Formycon AG 53.70 0.00% FYB.DE Formycon AG 53.60 -0.92% CUV.AX Clinuvel Pharmaceuticals Limited 12.10 -0.82% CVAC CureVac N.V. 3.7900 -0.79% CORT Corcept Therapeutics Incorporated 66.92 -4.26% NTLA Intellia Therapeutics, Inc. 10.32 -1.81%